NZ602820A - Lipid-containing compositions and methods of use thereof - Google Patents

Lipid-containing compositions and methods of use thereof

Info

Publication number
NZ602820A
NZ602820A NZ602820A NZ60282009A NZ602820A NZ 602820 A NZ602820 A NZ 602820A NZ 602820 A NZ602820 A NZ 602820A NZ 60282009 A NZ60282009 A NZ 60282009A NZ 602820 A NZ602820 A NZ 602820A
Authority
NZ
New Zealand
Prior art keywords
omega
subject
ratio
dosage
formulation provides
Prior art date
Application number
NZ602820A
Inventor
Urvashi Bhagat
Original Assignee
Asha Nutrition Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US12/426,034 external-priority patent/US20090264520A1/en
Application filed by Asha Nutrition Sciences Inc filed Critical Asha Nutrition Sciences Inc
Publication of NZ602820A publication Critical patent/NZ602820A/en

Links

Abstract

Patent No. 602820 Disclosed is a method of selecting a lipid-containing formulation for administration to a subject, comprising: a) evaluating the subject on the basis of one or more factors selected from: age of the subject, sex of the subject, diet of the subject, the body weight of the subject, physical activity level of the subject, lipid tolerance of the subject, medical conditions of the subject, family medical history of the subject, and ambient temperature range of the subject’s living area, and b) combining daily amounts of fatty acids comprising omega-6 and omega-3 fatty acids, wherein the ratio of omega-6 to omega-3 fatty acids and/or their amounts are controlled based on the one or more factors; wherein the formulation provides a dosage of omega-6 and omega-3 at an omega-6 to omega-3 ratio of 4:1 or greater; and/or the formulation provides a dosage of omega-6 and omega-3 at an omega-6 to omega-3 ratio of 1:1 to 10:1 if the subject has a diet of low antioxidants and/or low phytochemicals; and/or the formulation provides a dosage of omega-6 and omega-3 at an omega-6 to omega-3 ratio of 4:1 to 45:1 if the subject has a diet of high antioxidants and/or high phytochemicals; or the formulation provides a dosage of omega-6 and omega-3 at an omega-6 to omega-3 ratio of 2:1 to 30:1 if the subject has a diet of high seafood; and/or the formulation provides a dosage of omega-6 and omega-3 at an omega-6 to omega-3 ratio of 1:1 to 45:1 based on lipid tolerance of the subject; and/or the formulation provides a dosage of omega-6 and omega-3 at an omega-6 to omega-3 ratio of 1:1 to 50:1 if the subject has a condition wherein gradual increase of omega-6 and/or gradual withdrawal of omega-3 is necessary.
NZ602820A 2008-04-21 2009-04-20 Lipid-containing compositions and methods of use thereof NZ602820A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US4674708P 2008-04-21 2008-04-21
US7570808P 2008-06-25 2008-06-25
US11159308P 2008-11-05 2008-11-05
US12/426,034 US20090264520A1 (en) 2008-04-21 2009-04-17 Lipid-containing compositions and methods of use thereof
NZ589357A NZ589357A (en) 2008-04-21 2009-04-20 Lipid-containing compositions and methods of use thereof

Publications (1)

Publication Number Publication Date
NZ602820A true NZ602820A (en) 2014-01-31

Family

ID=54014403

Family Applications (2)

Application Number Title Priority Date Filing Date
NZ589357A NZ589357A (en) 2008-04-21 2009-04-20 Lipid-containing compositions and methods of use thereof
NZ602820A NZ602820A (en) 2008-04-21 2009-04-20 Lipid-containing compositions and methods of use thereof

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NZ589357A NZ589357A (en) 2008-04-21 2009-04-20 Lipid-containing compositions and methods of use thereof

Country Status (1)

Country Link
NZ (2) NZ589357A (en)

Also Published As

Publication number Publication date
NZ589357A (en) 2015-08-28

Similar Documents

Publication Publication Date Title
MX2019010738A (en) Lipid-containing compositions and methods of use thereof.
NZ610282A (en) Optimized nutritional formulations, methods for selection of tailored diets therefrom, and methods of use thereof
GB2459809A (en) Fatty acid formulations and methods of use thereof
WO2012087742A3 (en) Methods and compositions suitable for managing blood glucose in animals
MX2013007612A (en) Non-medical increase or maintenance of body weight of a mammal.
ES2571856T3 (en) Use of nutritional compositions to prevent visceral adiposity
NO20083735L (en) Dietary supplement preparation for blood lipid health
PH12016500100A1 (en) Self-emulsifying composition of omega3 fatty acid
EP3278800A3 (en) Compositions and methods for improving mitochondrial function and treating muscle-related pathological conditions
MX2011012375A (en) Extract of whole seeds of moringa sp., and use thereof in cosmetic and/or dermatological compositions.
BR112012033422A2 (en) high protein, low calorie nutritional compositions and methods of using them
NZ618734A (en) Polyunsaturated fatty acids for the treatment of diseases related to cardiovascular, metabolic and inflammatory disease areas
ES2659353T3 (en) Nutritional methods and formulations to increase efficacy and reduce the side effects of cancer treatment
SG193246A1 (en) Nutritional compositions for increasing arginine levels and methods of using same
BRPI0820068B8 (en) use of a yeast strain and/or a composition comprising a yeast strain for preparing a medicament
MX2017015037A (en) Nutritional compositions containing an elevated level of inositol and uses thereof.
BR112012012649A2 (en) human beta-defensin inducing agent, formulation, and uses of a human beta-defensin inducing agent, and at least one fat or oil of an essential fatty acid triglyceride or derivative thereof.
CA2578881A1 (en) Vitamin d compositions and method of administration to a human being
JP2014505702A5 (en)
PH12016500991B1 (en) Liquid milk fortifier composition with relatively high lipid content
BR112017027909A2 (en) composition and use of a composition
ES2664518T3 (en) Healthy food product containing ethyl esters of flaxseed oil fatty acids, and procedure for obtaining it
MX2010003843A (en) Orodispersible composition comprising polyunsaturated fatty acids without bad odour or taste.
TR201903470T4 (en) Formulation for personal hygiene.
WO2012075093A3 (en) Topical formulations for administration of omega-3 fatty acids

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 20 APR 2016 BY FB RICE

Effective date: 20140730

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 20 APR 2017 BY DAVIES COLLISON CAVE PTY LTD

Effective date: 20161020

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 20 APR 2018 BY CPA GLOBAL

Effective date: 20170311

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 20 APR 2019 BY EUROPEAN PATENT ANNUITY SERVICE GMBH

Effective date: 20180401

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 20 APR 2020 BY DR. STEFFEN SCHWARZ IPRIS AG

Effective date: 20190415

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 20 APR 2021 BY DENNEMEYER + CO

Effective date: 20200401

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 20 APR 2022 BY JAMES + WELLS

Effective date: 20210419

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 20 APR 2023 BY MADDERNS PTY LTD

Effective date: 20220414

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 20 APR 2024 BY PIPERS

Effective date: 20230405